Your browser doesn't support javascript.
loading
MLH1 germline mutation associated with Lynch syndrome in a family followed for more than 45 years.
Momma, Tomoyuki; Gonda, Kenji; Akama, Yoshinori; Endo, Eisei; Ujiie, Daisuke; Fujita, Shotaro; Maejima, Yuko; Horita, Shoichiro; Shimomura, Kenju; Saji, Shigehira; Kono, Koji; Yashima, Rei; Watanabe, Fumiaki; Sugano, Kokichi; Nomizu, Tadashi.
Afiliação
  • Momma T; Department of Gastrointestinal Tract Surgery, Fukushima Medical University, 1-Hikarigaoka, Fukushima city, Fukushima, 960-1295, Japan.
  • Gonda K; Center for Medical Genetics, Fukushima Medical University, 1-Hikarigaoka, Fukushima city, Fukushima, 960-1295, Japan.
  • Akama Y; Department of Gastrointestinal Tract Surgery, Fukushima Medical University, 1-Hikarigaoka, Fukushima city, Fukushima, 960-1295, Japan. gondake@fmu.ac.jp.
  • Endo E; Center for Medical Genetics, Fukushima Medical University, 1-Hikarigaoka, Fukushima city, Fukushima, 960-1295, Japan. gondake@fmu.ac.jp.
  • Ujiie D; Clinical Oncology Center, Fukushima Medical University Hospital, 1-Hikarigaoka, Fukushima city, Fukushima, 960-1295, Japan. gondake@fmu.ac.jp.
  • Fujita S; Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University, 1-Hikarigaoka, Fukushima city, Fukushima, 960-1295, Japan. gondake@fmu.ac.jp.
  • Maejima Y; Center for Medical Genetics, Fukushima Medical University, 1-Hikarigaoka, Fukushima city, Fukushima, 960-1295, Japan.
  • Horita S; Clinical Oncology Center, Fukushima Medical University Hospital, 1-Hikarigaoka, Fukushima city, Fukushima, 960-1295, Japan.
  • Shimomura K; Department of Gastrointestinal Tract Surgery, Fukushima Medical University, 1-Hikarigaoka, Fukushima city, Fukushima, 960-1295, Japan.
  • Saji S; Department of Gastrointestinal Tract Surgery, Fukushima Medical University, 1-Hikarigaoka, Fukushima city, Fukushima, 960-1295, Japan.
  • Kono K; Department of Gastrointestinal Tract Surgery, Fukushima Medical University, 1-Hikarigaoka, Fukushima city, Fukushima, 960-1295, Japan.
  • Yashima R; Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University, 1-Hikarigaoka, Fukushima city, Fukushima, 960-1295, Japan.
  • Watanabe F; Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University, 1-Hikarigaoka, Fukushima city, Fukushima, 960-1295, Japan.
  • Sugano K; Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University, 1-Hikarigaoka, Fukushima city, Fukushima, 960-1295, Japan.
  • Nomizu T; Clinical Oncology Center, Fukushima Medical University Hospital, 1-Hikarigaoka, Fukushima city, Fukushima, 960-1295, Japan.
BMC Med Genet ; 20(1): 67, 2019 05 02.
Article em En | MEDLINE | ID: mdl-31046708
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Hereditárias sem Polipose / Proteína 1 Homóloga a MutL Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Hereditárias sem Polipose / Proteína 1 Homóloga a MutL Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article